Swiss newspaper NZZ am Sonntag reported that the Swiss Competition Commission (COMCO) found evidence of a construction price fixing cartel that has allegedly overcharged municipal projects.
The belief is that the cartel includes hundreds of companies of all sizes and has even implicated politicians in canton Graubünden in southeastern Switzerland.
Specific projects being investigated include plans to renovate a rail tunnel and a hospital expansion which may have been overcharged 20%. The COMCO has been investigating since 2012 and is due to deliver a final report in a few weeks.
“The investigation into price fixing in canton Graubünden is one of the largest we have worked on,” COMCO vice-director Frank Stüssi told the newspaper. It is thought that construction companies met up to discuss lists of projects that would be shared out for inflated prices.
A whistleblower went to COMCO because he felt his complaints were not being taken seriously by the local authorities.
A guilty verdict brings the possibility of fines totaling millions of francs, which could threaten the existence of some smaller companies, according to industry experts.
Full Content: Swiss Info
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas